PenArg
General Information
DCTPep ID DCTPep02539
Peptide Name PenArg
Sequence RQIRIWFQNRRMRWRR
Sequence Length 16
UniProt ID Not available
PubChem CID 51032673
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Cell-penetrating peptides
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
HeLa WT | Human papillomavirus-related endocervical adenocarcinoma | 50% Cytotoxicity=36 ± 3.6 μM | MTS/PMS assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: HD50>128 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02539
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C104H168N42O20S1
Absent amino acids ACDEGHKLPSTVY
Theoretical pI 12.78
Acidic residues 0
Basic residues 7
Polar residues 1
Molecular weight (Average) 2358.81
Molecular weight (Monoisotopic) 2357.31
Common amino acids R
Net charge 7
Instability index (II) 124.1
Aliphatic index 48.75
Grand average of hydropathicity (GRAVY) -1.881
Half Life
1 hours (mammalian reticulocytes, in vitro).
2 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 11000
Abs 0.1% (=1 g/l) 4.663
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23085001
Title Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure
Doi 10.1016/j.bbamem.2012.10.010
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_8798